chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Patient had fever, chills , slight rash on  her adminstration site on the first day towards the evening . Then the fever went down on the second day and she was tired and rash started going down. Third day her rash was getting better. Now patient is ok .
Patient missed the second dose; Became infected with COVID-19 around the second week of April 2021; This case was received via an unknown source (no reference has been entered for a health authority or license partner) on 29-Jul-2021 and was forwarded to Moderna on 29-Jul-2021.    This spontaneous case was reported by a pharmacist and describes the occurrence of COVID-19 (Became infected with COVID-19 around the second week of April 2021) and PRODUCT DOSE OMISSION ISSUE (Patient missed the second dose) in a 63-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 045A21A) for COVID-19 vaccination.     The patient's past medical history included Type 2 diabetes mellitus and Seizures.    On 19-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) .5 milliliter. In April 2021, the patient experienced COVID-19 (Became infected with COVID-19 around the second week of April 2021). On 19-Apr-2021, the patient experienced PRODUCT DOSE OMISSION ISSUE (Patient missed the second dose). On 19-Apr-2021, PRODUCT DOSE OMISSION ISSUE (Patient missed the second dose) had resolved. At the time of the report, COVID-19 (Became infected with COVID-19 around the second week of April 2021) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Treatment medication were not reported. The healthcare professional reported that the patient was overweight, but her exact weight was unknown. The healthcare professional reported that the patient was on a "a lot of medications" but did not report them. The patient's second dose was in the series and was schedule for 19Apr2021 but the patient missed the second dose because she became infected with COVID-19.  The HCP stated that she became infected with COVID-19 around the second week of April 2021. The patient was now (29Jul2021) requesting to receive the second dose.       Reporter did not allow further contact
bilateral headaches; Severe fatigue; Fever; Swelling at injection site; redness; This case was reported by a pharmacist via call center representative and described the occurrence of fever in a elderly female patient who received Herpes zoster (Shingrix) for prophylaxis.   On an unknown date, the patient received the 1st dose of Shingrix. On an unknown date, unknown after receiving Shingrix, the patient experienced fever, injection site swelling, erythema, headache and fatigue. On an unknown date, the outcome of the fever, injection site swelling, erythema, headache and fatigue were recovered/resolved.   It was unknown if the reporter considered the fever, injection site swelling, erythema, headache and fatigue to be related to Shingrix.  Additional details were reported as follows: The age at vaccination was not reported. The patient experienced after 1st dose of Shingrix fever, swelling at injection site, redness,bilateral headaches an severe fatigue. The fever, swelling and redness gone in 3 to 4 days but fatigue and headaches for additional week. No additional details were given. The reporter did not consent to follow up.
Immediately after receiving vaccines pt noticed pain throughout arm. The following morning many bruises were very noticeable. Pain in (R) elbow joint.
03/23 Sore arm after shot for three days and general soreness in left shoulder. No other side effects, Soreness fade within a weeks 05/10 /2021: Woke up with what was felt like a closed eustachian tube (right side). Teble, high end hearing muted all day. Minor post nasal drip. 05/11/2021 No nasal drip, sounded better in the morning. By 12pm, hearing in my right ear is completely gone. 05/12/2021 Visit to GP : clean out ear with not relief. Simple Test confirms hearing loss is not viral but sensorinrual loss.
This case was reported by a pharmacist and described the occurrence of red rash injection site in a subject of unspecified age and gender who was vaccinated with FLUARIX (GlaxoSmithKline). In October 2008, the subject received a dose of FLUARIX (.5 ml, unknown). In October 2008, at an unspecified time after vaccination with FLUARIX, the subject experienced red rash injection site and pharmaceutical product complaint. The pharmacist received a call from a nurse at a nursing home facility that reported that 80 out of 100 subjects developed a "grapefruit size bright red" rash at the injection site. At the time of reporting the outcome of the events were unspecified. For the other 79 linked subjects please see cases: A0756483A - A0756558A, A0756560A - A0756562A. The CRC provided lot number AFLUA3208A to QA regarding this product complaint, while the report received in CMG Safety stated AFLUA3508A. With a possibility of a coding mistake to batch AFLUA320AA and on the basis that there are 80 cases out of 100, it was decided to ask for Quality investigation (including cold chain) of all three batches (correct numbers: AFLUA350BA, AFLUA320BA and AFLUA320AA). On 16 January 2009, QA results were received for batches reviewed of (AFLUA320AA and AFLUA320BA): AFLUACA320, AFLUA320A, and AFLUA320B. The report indicated that no deviation that could be linked to the complaint and no cold chain deviation was recorded on the batches AFLUA320AA and AFLUA320BA. On 26 March 2009, QA results were received for batches reviewed (AFLUA350BA): AFLUCA350 and AFLUA350B. The report indicated that no deviation that could be linked to the complaint and no cold chain deviation was recorded on the batch AFLUA350BA.
I developed a headache; This is a spontaneous report from a contactable consumer (patient). A 77-year-old female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number EL3246 and expiration date not provided), via an unspecified route of administration (left arm) first dose on 10Jan2021 17:00 at single dose for covid-19 immunisation. The patient's medical history included Anemia, Chronic Rhinitis, Rheumatoid Arthritis, Osteoarthritis, Kidney Disease Stage 3, and Gerd. The patient's concomitant medication included fexofenadine hydrochloride (ALLEGRA), rosuvastatin calcium (CRESTOR), prednisone, darbepoetin alfa (ARANESP), and clopidogrel. The patient previously took Phenergan and ACE inhibitors; both experienced allergies. On 16Jan2021 18:30, the patient developed a headache.  The patient did not received treatment for the event. The outcome of the event was unknown.
Heplisav-B 1st Dose 2nd Dose Received was Engerix; Initial Report Received on 25-Aug-2022.  A pharmacist reported that a 42 year-old female (race and ethnicity not provided) received HEPLISAV-B (hepatitis B vaccine) for hepatitis B immunization as the first dose and the second dose received was Engerix  .  No relevant medical history was reported.    No relevant concomitant medications were reported.    On 19-Jul-2022, the patient received the first dose of HEPLISAV-B (Lot # 937780, expiration date 14-Sep-2022 and NDC # 43528-003-05) in the left deltoid (route not provided).   On 19-Aug-2022, 31 days after having been vaccinated with HEPLISAV-B, the patient received Engerix. The patient reportedly experienced no adverse effects.   No additional information was reported.   Company Comment: The company assessed the event as non-serious.; Sender's Comments: The company assessed the event as non-serious.
It is my facility's policy to report to VAERS if a patient became COVID-19 positive with no symptoms after receiving the complete COVID-19 vaccine  series. Patient had a positive COVID-19 test in ER on 5/4/2021 and he completed his Moderna vaccine series on 2/16/2021 and 3/16/2021.  Patient was also previously COVID-19 positive on December 21, 2021.
101.3 temp developed 12 hrs after 2nd Vaccine. Fatigue and weakness lasted until I woke up on 1/26/2021 at 0500. Felt much better & no fever only problem was bilateral Lumbar pain. This pain was mild at first then worsened in the next two weeks also radiating to bilateral hips and buttock.  Worsening stiffness and loss of range of motion. Bending over or lifting legs particularly thighs to get in and out of my car was very difficult & painful. Got MRI of the back with was negative.Orthopedic Surgeon?s PA I saw. She felt it was probably a lumbar strain from possible exercise I had done.. Symptoms improved after activity & PT but returned in a day or so & worsened at a night. In the last month spread to shoulders. Got my Internist involved then. Inflammatory markers done 4/13/2021. C Reactive Protein positive at 2.8. Slightly anemia as well. All other markers negative. Polymyalgia Rheumatica diagnosed.  Started on Prednisone 20mg 4/14/2021. Symptoms improving greatly.
Shingrix vaccines were frozen; This case was reported by a other health professional via call center representative and described the occurrence of incorrect storage of drug in an unspecified number of patients who received Herpes zoster (Shingrix) for prophylaxis.   On an unknown date, the patient received Shingrix. On an unknown date, unknown after receiving Shingrix, the patient experienced incorrect storage of drug. On an unknown date, the outcome of the incorrect storage of drug was unknown.  Additional details were provided as follows: The age at vaccination was not applicable for this report. The health care provided wanted to know how to proceed with some Shingrix vaccines being frozen, which led to incorrect storage of drug. The health care professional's demographic details were provided for a callback. Health care professional could not be contacted in order to collect further details of the event. Only information provided was that some Shingrix vaccines were frozen.
Muscle spasms in her arms and legs; This case was reported by a consumer via call center representative and described the occurrence of muscle spasm in a female patient who received Rabies NVS (RabAvert) for prophylaxis.   The patient's past medical history included animal bite and tingling (Prior to getting the vaccine, the patient had tingling in her left arm).   On an unknown date, the patient received RabAvert at an unknown dose. On an unknown date, unknown after receiving RabAvert, the patient experienced muscle spasm. On an unknown date, the outcome of the muscle spasm was recovering/resolving.   It was unknown if the reporter considered the muscle spasm to be related to RabAvert.  Additional details were provided as follows: The case was reported by patient's parent. The age at vaccination was not reported. It was reported as the patient was given the series of the Rabavert vaccine after exposure to a bat.  Prior to getting the vaccine, the patient had tingling in her left arm.  After receiving the vaccine the patient had muscle spasms in her arms and legs and patient visited the emergency room four times.  The reporter did not consent to follow up.
I noticed a pattern of blisters on my hand. That was unusual, I then started noticing them on other parts of my body and moving across my arms and onto my back. I thought maybe I got into a weed or plant but really could not find anything that would have done that. I then went through if there was anything new environmentally- did we change laundry detergent or soap but nothing had really changed. I spoke with my daughter who is an RN and we decided to wait about two weeks to see how it changed or if it got better. I ended up calling my doctor at the three week mark. It had gotten worse and I even had the blisters in my mouth. We even talked about Monkey Pox as this was the time frame that Monkey Pox was coming. We did a bunch of tests for different things and they all came back negative. My PCP sent me to an ENT since I was having the blisters in my mouth and a Dermatologist as well. The Dermatologist had me stop my medication Allopurinol to see if that was maybe a cause. I had been on that medication for years but it was worth a try. I had an appointment with my dentist who said this looked like Lichen Planus- the dentist knew this because his Father has Lichen Planus. I was able to get into the ENT and they were able to test for that and thought yes this looked like it could be. I was diagnosed with Bullous Lichen Planus and have gotten on some medication and topical steroids' to help the symptoms. I do not have a spot large enough to do a biopsy but we are managing the symptoms and figuring out the care plan to manage this since there is not a cure.
Information has been received from a physician concerning a 11 year old female with bronchospasm exercise induced who n 21-APR-2009 was vaccinated with 0.5 mL first dose of GARDASIL (lot # 661764/0650X). Concomitant therapy included MENACTRA (lot # U2866AA), ADACEL (lot # UF455BA) and a rescue inhaler. The patient experienced syncope after the GARDASIL vaccine. The patient was given water and supportive care. The physician caught her or she would have fallen. The patient experienced a true syncope episode complete with blurry vision. Her vitals were normal when left and she was considered recovered on the same date. Additional information has been requested.
HERPES ACTIVATION, URINARY  ANAL STRICTURE WITH PAINFUL LIMITED URINATIN ABD DEFACATION' aLSO PAINFUL SWOLEN LYMPH NODE UNDER LEFT ARM OF INJECTION ARM.
Sudden onset of chills about 12 hours after vaccination.  Uncontrollable shivering for 30 minutes before stabilized with hot bath. Fever of 99-101F the next morning. Headaches, congestion, fever,  and chills still present 36 hours after vaccination.
Felt light headed and dizzy for greater than 30 mins. Symptoms weren't not subsiding. EMS was called and  was transported to a local hospital via ambulance.
Patient came in December for a redo of all vaccines due to stem cell transplant. He was to get his second dose, in the primary series of 3,  in January, rather, he received a booster.
warmth, pain and little red bumps at the injection site; pain at the injection site; little red bumps at the site; itching at the site; warmth at the injection site; Initial information received on 05-Oct-2020 regarding an unsolicited valid non-serious case from a pharmacist.  This case involves a 74-years-old male patient who had warmth, pain and little red bumps at the injection site (vaccination site inflammation) and itching at the site (vaccination site pruritus), while he received INFLUENZA QUADRIVAL A-B HIGH DOSE HV VACCINE [FLUZONE HIGH-DOSE QUADRIVALENT].  Medical history, past medical treatments, vaccinations and family history were not provided.  Concomitant medications were not reported.  On 25-Sep-2020, the patient received a dose of 0.7 mL suspect INFLUENZA QUADRIVAL A-B HIGH DOSE HV VACCINE (lot UJ487AB, expiry date-30-Jun-2020) via intramuscular route in the left arm for prophylactic vaccination.  On an unknown date in 2020, the patient developed a non-serious warmth, pain and little red bumps at the injection site (vaccination site inflammation) with symptoms of warmth at the injection site (vaccination site warmth) and pain at the injection site (vaccination site pain) four days following the administration of INFLUENZA QUADRIVAL A-B HIGH DOSE HV VACCINE.  On an unknown date in 2020, the patient developed a non-serious little red bumps at the site (vaccination site erythema) symptom of (vaccination site inflammation) and itching at the site (vaccination site pruritus) two weeks following the administration of INFLUENZA QUADRIVAL A-B HIGH DOSE HV VACCINE.  No laboratories details reported.  It was not reported if the patient received any corrective treatment.  Outcome of events was unknown at the time of reporting.
Client informed RN that after 1st Moderna Vaccine on 04/09/21 she experienced bumps in her mouth and on her chin. Client went to PMD at Kaiser 24 hours later who diagnosed her with fever blisters. Client states " There was no fluid in the bumps." Client experienced one small raised area to the lower lip 32 minutes after the 2nd Moderna COVID vaccine on 05/07/2021, no distress noted. Client advised to follow up with PMD doctor and use emergency medical services as needed. Client verbalized an understanding
The patient received their first Moderna vaccine while he was under the approved age of 18. The patient did not have any adverse events after the shot. I notified the guardian after the shot was administered that the shot was not approved for patients under the age of 18. The guardian understood and signed the consent form along with the patient's signature. Let the guardian know if they have any questions or concerns to please call the pharmacy at any time
1/2/21-  1/5/21 Fever, chils, arthralgias, swollen throat, nausea, BLURRY VISION, RED eyes, white noise in ears, fatigue lacinating pain ankles, knees ,wrist and finger joints; pain along nerves and vessels fingers with  right fourth DIP ulnar side  small vessel bleed hematoma  4 cm x 4cm swelling; NO trauma sedenatry  Saw Urgent care  1/4/21 -with negative  covid 19, strep and flu  tests said was repsonse to vaccine Saw primary  1/5/21 Dr hopsital, said probably had covid before and was repsonse to vaccine. 1/6/21;  all  fingers still swollen no pain  most other symptoms improving but TIRED
Shaking; General aches and pain; Hard to remember things; Severe tremors/vaccine has made it worse; Fever; Headache/ mild headache; Alternating fever and chills; Chills/ chills were so bad that her husband had to hold he glass for her to drink; This spontaneous case was reported by a consumer and describes the occurrence of TREMOR (Shaking), PAIN (General aches and pain), MEMORY IMPAIRMENT (Hard to remember things), TREMOR (Severe tremors/vaccine has made it worse) and PYREXIA (Fever) in a 78-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included Familial tremor (Patient states she has non-essential/familial tremor which she has had for 20 years). Concomitant products included PROBIOTICS NOS, AMINOBENZOIC ACID, BIOTIN, CHOLINE BITARTRATE, FOLIC ACID, INOSITOL, LECITHIN, VITAMIN B NOS (B100), CALCIUM CITRATE, COLECALCIFEROL (CITRICAL D), FAMOTIDINE, FOLIC ACID, GABAPENTIN, LEVOTHYROXINE, MELATONIN, OXYBUTYNIN, PRIMIDONE, PROPRANOLOL, TOPIRAMATE, VALACICLOVIR HYDROCHLORIDE (VALACYCLOVIR HCL), VITAMIN B1 NOS and VITAMIN D3 for an unknown indication.    On 26-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced TREMOR (Shaking), PAIN (General aches and pain), MEMORY IMPAIRMENT (Hard to remember things), TREMOR (Severe tremors/vaccine has made it worse), PYREXIA (Fever), CHILLS (Chills/ chills were so bad that her husband had to hold he glass for her to drink), HEADACHE (Headache/ mild headache) and PYREXIA (Alternating fever and chills). The patient was treated with ACETYLSALICYLIC ACID (ASPIRIN [ACETYLSALICYLIC ACID]) for Headache and Fever, at a dose of UNK dosage form; PARACETAMOL (TYLENOL) for Pain, Fever and Headache, at a dose of UNK dosage form and TRAMADOL for Pain, at a dose of UNK dosage form. At the time of the report, TREMOR (Shaking), PAIN (General aches and pain), MEMORY IMPAIRMENT (Hard to remember things), TREMOR (Severe tremors/vaccine has made it worse), PYREXIA (Fever), CHILLS (Chills/ chills were so bad that her husband had to hold he glass for her to drink), HEADACHE (Headache/ mild headache) and PYREXIA (Alternating fever and chills) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.
After the first shot I got these spots that were sore and itchy with a little blister center on tops of both arms but on the right arm first then about a week later the left arm, which is the site of injection.  I initially thought they were spider bites but have seen no spiders, insects etc.  They subsided and then returned after the second shot on 3/11/21 again initially on the right arm and then the left then a couple on the right side of my face then a week later on the left side of my face.  Yesterday they returned to the top of both arms. They seem to improve with Bynadryl.
Appr. 1 1/2-22k after flu shot, began to have neck and right shoulder pain all down arm with numbness/tingling. Then by the 1st week of November unable to lift right arm all way up and constant pain from neck all the way down shoulder and arm.
BODY ACHING; HEADACHE; This spontaneous report received from a patient concerned a patient of unspecified age and sex. The patient's weight, height, and medical history were not reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: Unk) dose was not reported, administered on 17-MAR-2021 for prophylactic vaccination. The batch number was not reported. Per procedure, no follow-up will be requested for this case. No concomitant medications were reported.  On MAR-2021, the subject experienced body aching. On MAR-2021, the subject experienced headache. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The outcome of the headache and body aching was not reported. This report was non-serious.
26 doses of COVID-19 vaccines of moderna were administered past expiration date; This spontaneous case was reported by a nurse and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (26 doses of COVID-19 vaccines of moderna were administered past expiration date) in a 35-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 033H21A) for COVID-19 vaccination.     Previously administered products included for Product used for unknown indication: COVID-19 Vaccine (first dose) on 11-Mar-2021 and COVID-19 Vaccine (second dose) on 20-Apr-2021. Past adverse reactions to the above products included No adverse event with COVID-19 Vaccine and COVID-19 Vaccine. Concurrent medical conditions included HIV disease. Concomitant products included AZITHROMYCIN (ZITHROMAX), MOMETASONE FUROATE (NASONEX), BICTEGRAVIR SODIUM, EMTRICITABINE, TENOFOVIR ALAFENAMIDE FUMARATE (BIKTARVY) and VITAMIN D [VITAMIN D NOS] for an unknown indication.    On 07-Feb-2022, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 07-Feb-2022, the patient experienced EXPIRED PRODUCT ADMINISTERED (26 doses of COVID-19 vaccines of moderna were administered past expiration date). At the time of the report, EXPIRED PRODUCT ADMINISTERED (26 doses of COVID-19 vaccines of moderna were administered past expiration date) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   Patient had no known allergies. The patient had a clinical history of human immunodeficiency virus (HIV) and was under treatment for this illness.  It was reported by Health care professional that they administered Moderna COVD-19 Vaccine to 26 patients from 5 vials that were stored in the fridge for more than 30 days.  The vials had been moved to the fridge on 28-Dec-2021 and had the expiration date of 27-Jan-2022 (30 days at fridge temps). The expiration date was not caught in time and these doses were administered in error.  Reporter did not know if the patient had experienced any symptoms after vaccination. Treatment information was not provided.   Most recent FOLLOW-UP information incorporated above includes: On 08-Feb-2022: Follow up information received included significant information. The case was initially invalid and it was updated to a valid case. Patient Demographics, medical history and concomitant medications were added.